E-LIB Suche - Ergebnisse für: Anna Katharina Seitz

1

Reliability of continuous vital sign monitoring in post-ope..:

Helmer, Philipp ; Hottenrott, Sebastian ; Wienböker, Kathrin...
DIGITAL HEALTH. 10 (2024) - p. , 2024

2

SUVmean on baseline [18F]PSMA-1007 PET and clinical paramet..:

Hartrampf, Philipp E. ; Hüttmann, Thomas ; Seitz, Anna Katharina...
European Journal of Nuclear Medicine and Molecular Imaging. 50 (2023) 11 - p. 3465-3474 , 2023

Link: https://doi.org/10.1007/..

3

Preliminary results regarding automated identification of p..:

Roch, Carmen ; Kielkopf, Julian Alexander ; Stefenelli, Ulrich...
Urologic Oncology: Seminars and Original Investigations. 41 (2023) 5 - p. 255.e1-255.e6 , 2023

Link: https://doi.org/10.1016/..

4

Reduced Segmentation of Lesions Is Comparable to Whole-Body..:

Hartrampf, Philipp E. ; Krebs, Markus ; Peter, Lea...
Biology. 11 (2022) 5 - p. 660 , 2022

Link: https://doi.org/10.3390/..

5

Diverse PSMA expression in primary prostate cancer: reason ..:

Cytawa, Wojciech ; Kircher, Stefan ; Kübler, Hubert...
European Journal of Nuclear Medicine and Molecular Imaging. 49 (2022) 11 - p. 3938-3949 , 2022

Link: https://doi.org/10.1007/..

6

Baseline clinical characteristics predict overall survival ..:

Hartrampf, Philipp E. ; Seitz, Anna Katharina ; Weinzierl, Franz-Xaver...
European Journal of Nuclear Medicine and Molecular Imaging. 49 (2022) 12 - p. 4262-4270 , 2022

Link: https://doi.org/10.1007/..

7

Any decline in prostate‐specific antigen levels identifies ..:

Hartrampf, Philipp E. ; Weinzierl, Franz‐Xaver ; Seitz, Anna Katharina...
The Prostate. 82 (2022) 14 - p. 1406-1412 , 2022

Link: https://doi.org/10.1002/..

8

Hematotoxicity and Nephrotoxicity in Prostate Cancer Patien..:

Hartrampf, Philipp E. ; Weinzierl, Franz-Xaver ; Serfling, Sebastian E....
Cancers. 14 (2022) 3 - p. 647 , 2022

Link: https://doi.org/10.3390/..

9

Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-P..:

Hartrampf, Philipp E. ; Weinzierl, Franz-Xaver ; Buck, Andreas K....
European Journal of Nuclear Medicine and Molecular Imaging. 49 (2022) 9 - p. 3269-3276 , 2022

Link: https://doi.org/10.1007/..

10

mCRPC patients with PSA fluctuations under radioligand ther..:

Hartrampf, Philipp E. ; Bundschuh, Ralph A. ; Weinzierl, Franz-Xaver...
European Journal of Nuclear Medicine and Molecular Imaging. 49 (2022) 13 - p. 4727-4735 , 2022

Link: https://doi.org/10.1007/..

11

Development of Discordant Hypermetabolic Prostate Cancer Le..:

Hartrampf, Philipp E. ; Lapa, Constantin ; Serfling, Sebastian E....
Cancers. 13 (2021) 17 - p. 4270 , 2021

Link: https://doi.org/10.3390/..

12

Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate ..:

Hartrampf, Philipp E. ; Heinrich, Marieke ; Seitz, Anna Katharina...
Journal of Clinical Medicine. 9 (2020) 5 - p. 1390 , 2020

Link: https://doi.org/10.3390/..

13

Prognostic implications of dual tracer PET/CT: PSMA ligand ..:

Michalski, Kerstin ; Ruf, Juri ; Goetz, Christian...
European Journal of Nuclear Medicine and Molecular Imaging. 48 (2020) 6 - p. 2024-2030 , 2020

Link: https://doi.org/10.1007/..

14

Detection Rate of 68Ga-PSMA Ligand PET/CT in Patients with ..:

Brumberg, Joachim ; Beckl, Melanie ; Dierks, Alexander...
Biomedicines. 8 (2020) 11 - p. 511 , 2020

Link: https://doi.org/10.3390/..

15

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer:

Cytawa, Wojciech ; Seitz, Anna Katharina ; Kircher, Stefan...
European Journal of Nuclear Medicine and Molecular Imaging. 47 (2019) 1 - p. 168-177 , 2019

Link: https://doi.org/10.1007/..